StonvexLoading…
StonvexStonvexStonvexCore line items from EXEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-02 | Annual 2025 2025-01-03 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $2.32B | $2.17B | $1.83B | $1.61B |
Operating Income | $872.19M | $604.62M | $170.88M | $201.48M |
Net Income | $782.57M | $521.27M | $207.76M | $182.28M |
EPS (Diluted) | $2.78 | $1.76 | $0.65 | $0.56 |
Total Assets | $2.84B | $2.95B | $2.94B | $3.07B |
Total Liabilities | $683.10M | $703.49M | $678.45M | $583.06M |
Cash & Equivalents | $482.49M | $217.37M | $262.99M | $501.19M |
Free Cash Flow OCF − CapEx | $875.84M | $671.54M | $292.86M | $334.91M |
Shares Outstanding | 262.48M | 281.73M | 302.79M | 323.95M |